Unraveling Cancer

Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from active therapy to surveillance.

In this episode of Patient Power’s podcast Unraveling Cancer, patient host Michele Nadeem-Baker sits down with Lucy Potter, MD, MPH, MD Anderson, for a conversation about one of the most common challenges in cancer care: fatigue. They explore practical behavioral strategies to ease day-to-day exhaustion, discuss when medications may be helpful, and highlight key tests that can uncover underlying causes.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Deborah Stephens, DO, UNC at Chapel Hill, for a conversation about choosing a treatment for CLL, when to consider a clinical trial and the pros and cons of fixed duration vs continuous therapy.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Kerry Rogers, MD, from The Ohio State University, for a conversation about preparing for an upcoming doctor’s visit, how to have a productive conversation about treatment decisions and what to do when you don’t feel you are being heard.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Brad Adams is joined by Thomas Kipps, MD UC San Diego, for a conversation about why the move from chemotherapy to targeted treatments is a game changer for older CLL patients and those with co-morbidities.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Larry Fagan is joined by Benjamin Heyman, MD, UC San Diego, for a conversation about frontline therapies for mantle cell lymphoma, the results from the ECHO trial, and the role of combination treatments in a frontline setting moving forward.

In this episode of the Patient Power podcast, Unraveling Cancer, Patient Power host, Ruth Fein and Lauren Madigan, MD, University of Utah, discuss a multi-disciplinary approach for diagnosis and treatment of systemic mastocytosis, the role of dermatology in identifying and managing skin-related symptoms, and what is in the pipeline for new therapies in the future.

In this episode of Unraveling Cancer, Patient Power host, Michelle Nadine-Baker, is joined byKerry A. Rogers, MD, The Ohio State University Comprehensive Cancer Center – The James, to explore the importance of building a comprehensive healthcare team, scheduling regular screenings, and ensuring you and your support network are equipped for the journey ahead.

In this episode of the Patient Power podcast Unraveling Cancer, we explore indolent systemic mastocytosis. Patient Power host Ruth Fein is joined by John Fahrenholz, MD, Vanderbilt University Medical Center, to discuss diagnosis, emerging treatments like avapritinib, and the importance of patient advocacy and collaboration between specialists.

“Smart Patients get Smart Care” Brian Koffman, MD, Chief Medical Officer and Executive Vice President of The CLL Society, joins Patient Power co-founder, Andrew Schorr to advocate for clinical trials.

For more on on CLL, visit us on Patient Power,

https://www.patientpower.info/chronic-lymphocytic-leukemia

In this episode of the Patient Power podcast, Unraveling Cancer, Patient Power host, Zach Berkowitz is joined by Dr. Aaron Gerds, Cleveland Clinic, to discuss the difficulties patients face coordinating care between health care providers, the importance of advocating for oneself and the exciting approvals of new treatments for systemic mastocytosis.